Phase 2 Acral Melanoma trials recruiting now

All Acral Melanoma trials, every phase

Phase 2 Acral Melanoma trials

• A Beta-only IL-2 ImmunoTherapY Study
  NCT05086692 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 27 locations
• Camrelizumab Plus Apatinib and Temozolomide as Neoadjuvant in High Risk Acral Melanoma
  NCT05512481 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Neoadjuvant SHR-1210 Plus Apatinib for Resectable Stage III-IV Acral Melanoma
  NCT04331093 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Perioperative Toripalimab and Endostatin for Stage II Melanoma: A Phase II Trial
  NCT06965231 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 4 locations

Common questions

What does Phase 2 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.